应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
CTY City Therapeutics
休市中 10-16 16:00:00 EDT
22.40
+4.40
+24.44%
盘后
21.72
-0.68
-3.03%
19:58 EDT
最高
23.88
最低
20.50
成交量
140.64万
今开
23.00
昨收
18.00
日振幅
18.78%
总市值
11.27亿
流通市值
2.17亿
总股本
5,033万
成交额
3,109万
换手率
14.50%
流通股本
970.00万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
RNAi药物开发商City纳斯达克上市:市值11亿美元 路演PPT曝光
雷递网 · 09:25
RNAi药物开发商City纳斯达克上市:市值11亿美元 路演PPT曝光
美股异动 | 生物技术公司City Therapeutics(CTY.US)登陆美股市场 开盘后涨近24%
智通财经 · 00:00
美股异动 | 生物技术公司City Therapeutics(CTY.US)登陆美股市场 开盘后涨近24%
富达、Arch站台,RNAi新锐City Therapeutics(CTY.US)冲刺美股IPO,拟募资至多1.85亿美元
智通财经 · 10-09
富达、Arch站台,RNAi新锐City Therapeutics(CTY.US)冲刺美股IPO,拟募资至多1.85亿美元
加载更多
公司概况
公司名称:
City Therapeutics
所属市场:
NASDAQ
上市日期:
--
主营业务:
City Therapeutics, Inc.于2023年7月17日在特拉华州注册成立。该公司是一家临床阶段的生物技术公司,开发下一代RNAi疗法,旨在抑制疾病相关蛋白的表达,为有需要的患者提供有意义且持久的治疗获益。其管线聚焦于血栓栓塞性疾病、Stargardt病1型和慢性病贫血等重大未满足医疗需求。
发行价格:
--
{"stockData":{"symbol":"CTY","market":"US","secType":"STK","nameCN":"City Therapeutics","latestPrice":22.4,"timestamp":1792180800000,"preClose":18,"halted":0,"volume":1406415,"hourTrading":{"tag":"盘后","latestPrice":21.7207,"preClose":22.4,"latestTime":"19:58 EDT","volume":21209,"amount":474569.4843,"timestamp":1792195130026,"change":-0.6793,"changeRate":-0.030326,"amplitude":0.030326},"delay":0,"changeRate":0.24444444444444435,"floatShares":9700000,"shares":50332300,"eps":-1.742,"marketStatus":"休市中","change":4.4,"latestTime":"10-16 16:00:00 EDT","open":23,"high":23.88,"low":20.5,"amount":31089127.050449997,"amplitude":0.187778,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.742,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1792396800000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1792123200000,"exchange":"NASDAQ","adjPreClose":18,"postHourTrading":{"tag":"盘后","latestPrice":21.7207,"preClose":22.4,"latestTime":"19:58 EDT","volume":21209,"amount":474569.4843,"timestamp":1792195130026,"change":-0.6793,"changeRate":-0.030326,"amplitude":0.030326},"volumeRatio":0},"requestUrl":"/m/hq/s/CTY","defaultTab":"news","newsList":[{"id":"2676754894","title":"RNAi药物开发商City纳斯达克上市:市值11亿美元 路演PPT曝光","url":"https://stock-news.laohu8.com/highlight/detail?id=2676754894","media":"雷递网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676754894?lang=zh_cn&edition=full","pubTime":"2026-10-17 09:25","pubTimestamp":1792200304,"startTime":"0","endTime":"0","summary":"RNAi药物开发商City Therapeutics Inc(股票代码:“CTY”)昨日在美国纳斯达克上市。","market":"hk","thumbnail":"https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20261017/6392782587904902396083702.jpeg","type":0,"news_type":0,"thumbnails":["https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20261017/6392782587904902396083702.jpeg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.leinews.com/n35423/detail.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"leinews_highlight","symbols":["CTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676516184","title":"美股异动 | 生物技术公司City Therapeutics(CTY.US)登陆美股市场 开盘后涨近24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2676516184","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676516184?lang=zh_cn&edition=full","pubTime":"2026-10-17 00:00","pubTimestamp":1792166400,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,周五,City Therapeutics登陆美股市场,截至发稿,该股涨近24%,报22.315美元。City Therapeutics是一家总部位于美国马萨诸塞州剑桥市的临床阶段生物技术公司,成立于2023年,专注于开发新一代RNA干扰疗法,通过抑制与疾病相关的特定蛋白质表达,治疗具有重大未满足医疗需求的疾病。公司由RNAi领域资深专家创立,联合创始人兼执行董事长John Maraganore曾担任RNAi制药先驱Alnylam的首席执行官。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1508627.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LENZ","HELX","BK4539","BK4139","CTY","BK4007","WDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674851717","title":"富达、Arch站台,RNAi新锐City Therapeutics(CTY.US)冲刺美股IPO,拟募资至多1.85亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2674851717","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674851717?lang=zh_cn&edition=full","pubTime":"2026-10-09 20:23","pubTimestamp":1791548622,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IPOS","BK4139","BK4007","FRHC","BK4127","BK4539","LENZ","KCE","CTY","REDS"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.citytx.com","stockEarnings":[{"period":"1week","weight":0.2444},{"period":"ytd","weight":0.2444}],"compareEarnings":[{"period":"1week","weight":-0.0197},{"period":"1month","weight":0.0122},{"period":"3month","weight":0.0269},{"period":"6month","weight":0.0748},{"period":"1year","weight":0.1553},{"period":"ytd","weight":0.1193}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"City Therapeutics, Inc.于2023年7月17日在特拉华州注册成立。该公司是一家临床阶段的生物技术公司,开发下一代RNAi疗法,旨在抑制疾病相关蛋白的表达,为有需要的患者提供有意义且持久的治疗获益。其管线聚焦于血栓栓塞性疾病、Stargardt病1型和慢性病贫血等重大未满足医疗需求。","exchange":"NASDAQ","name":"City Therapeutics","nameEN":"City Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"City Therapeutics(CTY)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供City Therapeutics(CTY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"City Therapeutics,CTY,City Therapeutics股票,City Therapeutics股票老虎,City Therapeutics股票老虎国际,City Therapeutics行情,City Therapeutics股票行情,City Therapeutics股价,City Therapeutics股市,City Therapeutics股票价格,City Therapeutics股票交易,City Therapeutics股票购买,City Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"City Therapeutics(CTY)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供City Therapeutics(CTY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}